Home › Funds › Wellington Shields & Co., LLC › PSNL
Wellington Shields & Co., LLC position in PSNL
PERSONALIS INC · Health Care
Wellington Shields & Co., LLC reported holding 292,489 shares of PSNL (PERSONALIS INC) in its Q2 2026 13F filing — a position valued at US$3.9M, representing 0.88% of its reported portfolio and ranking #26 among its reported holdings. Wellington Shields & Co., LLC has disclosed PSNL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Wellington Shields & Co., LLC's PSNL position evolved
Wellington Shields & Co., LLC first disclosed a stake in PSNL in Q3 2023 at 604,267 shares (US$731K). The position peaked in Q2 2026 at 292,489 shares, worth US$3.9M. Across 12 filings, Wellington Shields & Co., LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 292,489 shares valued at US$3.9M. Notable position changes include a 51% trim in Q4 2023 (shares fell 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 604.27K | $731.16K | New |
| Q4 2023 | 294.10K | $617.60K | Reduce |
| Q1 2024 | 294.10K | $617.60K | Hold |
| Q2 2024 | 292.49K | $342.21K | Reduce |
| Q3 2024 | 292.49K | $1.57M | Hold |
| Q4 2024 | 292.49K | $1.69M | Hold |
| Q1 2025 | 292.49K | $1.03M | Hold |
| Q2 2025 | 292.49K | $1.92M | Hold |
| Q3 2025 | 292.49K | $1.91M | Hold |
| Q4 2025 | 292.49K | $2.33M | Hold |
| Q1 2026 | 292.49K | $1.86M | Hold |
| Q2 2026 | 292.49K | $3.92M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PSNL and 13F data
PSNL (PERSONALIS INC) is a Health Care company. 61 other funds we track also report a position in PSNL — the largest reported positions include Merck & Co., Inc. (US$188.2M), ARK Invest (US$110.8M), Lightspeed Management Company, L.L.C. (US$81.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PSNL
- Merck & Co., Inc. 14.04M sh · $188.20M · Q2 2026
- ARK Invest 8.27M sh · $110.84M · Q2 2026
- Lightspeed Management Company, L.L.C. 6.10M sh · $81.76M · Q2 2026
- Deep Track Capital, LP 4.00M sh · $53.60M · Q2 2026
- Casdin Capital 2.55M sh · $34.17M · Q2 2026
- KENNEDY CAPITAL MANAGEMENT LLC 2.36M sh · $31.68M · Q2 2026
- AIGH Capital Management LLC 1.72M sh · $22.98M · Q2 2026
- Blue Water Life Science Advisors, LP 1.68M sh · $22.46M · Q2 2026
- Wellington Shields Capital Management, LLC 339.73K sh · $4.55M · Q2 2026
- PERKINS CAPITAL MANAGEMENT INC 239.00K sh · $3.20M · Q2 2026
- Bruce & Co., Inc. 233.00K sh · $3.12M · Q2 2026
- UDINE WEALTH MANAGEMENT, INC. 50.03K sh · $2.90M · Q2 2026
More on Wellington Shields & Co., LLC
FAQ
How long has Wellington Shields & Co., LLC held PSNL?
Wellington Shields & Co., LLC has disclosed PSNL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Wellington Shields & Co., LLC's current position in PSNL?
As of Q2 2026, Wellington Shields & Co., LLC holds 292.49K shares of PSNL (PERSONALIS INC), valued at $3.92M, representing 0.88% of its reported portfolio and ranking #26.
Has Wellington Shields & Co., LLC been buying or selling PSNL?
In the latest 13F filing (Q2 2026), Wellington Shields & Co., LLC held unchanged its position in PSNL. The position peaked in Q2 2026 at 292.49K shares.
Which other funds hold PSNL?
Other major institutional holders of PSNL include Merck & Co., Inc., ARK Invest, Lightspeed Management Company, L.L.C., among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.